Eve Wittenberg
Harvard University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Eve Wittenberg.
Diabetologia | 2006
Deborah J. Wexler; Richard W. Grant; Eve Wittenberg; Johanna L. Bosch; Enrico Cagliero; Linda M. Delahanty; Mark A. Blais; James B. Meigs
Aims/hypothesisWe assessed the impact of medical comorbidities, depression, and treatment intensity on quality of life in a large primary care cohort of patients with type 2 diabetes.MethodsWe used the Health Utilities Index-III, an instrument that measures health-related quality of life based on community preferences in units of health utility (scaled from 0=death to 1.0=perfect health), in 909 primary care patients with type 2 diabetes. Demographic and clinical correlates of health-related quality of life were assessed.ResultsThe median health utility score for this population was 0.70 (interquartile range 0.39–0.88). In univariate analyses, older age, female sex, low socioeconomic status, cardiovascular disease, microvascular complications, congestive heart failure, peripheral vascular disease, chronic lung disease, depression, insulin use and number of medications correlated with decreased quality of life, while obesity, hypertension and hypercholesterolaemia did not. In multiple regression analyses, microvascular complications, heart failure and depression were most strongly related to decreased health-related quality of life, independently of duration of diabetes; in these models, diabetes patients with depression had a utility of 0.59, while patients without symptomatic comorbidities did not have a significantly reduced quality of life. Treatment intensity remained a significant negative correlate of quality of life in multivariable models.Conclusions/interpretationPatients with type 2 diabetes have a substantially decreased quality of life in association with symptomatic complications. The data suggest that treatment of depression and prevention of complications have the greatest potential to improve health-related quality of life in type 2 diabetes.
Diabetic Medicine | 2007
Linda M. Delahanty; Richard W. Grant; Eve Wittenberg; Johanna L. Bosch; Deborah J. Wexler; Enrico Cagliero; James B. Meigs
Aims To characterize the determinants of diabetes‐related emotional distress by treatment modality (diet only, oral medication only, or insulin).
Laryngoscope | 2011
Zachary M. Soler; Eve Wittenberg; Rodney J. Schlosser; Jess C. Mace; Timothy L. Smith
The primary study goal was to measure health state utility values in patients with chronic rhinosinusitis (CRS) before and after undergoing endoscopic sinus surgery (ESS). A secondary goal was to assess the meaning of these values by comparing them with other chronic disease processes and currently available medical or surgical treatments.
International Journal of Radiation Oncology Biology Physics | 2009
David J. Sher; Eve Wittenberg; W. Warren Suh; Alphonse G. Taghian; Rinaa S. Punglia
PURPOSE Accelerated partial-breast irradiation (PBI) is a new treatment paradigm for patients with early-stage breast cancer. Although PBI may lead to greater local recurrence rates, it may be cost-effective because of better tolerability and lower cost. We aim to determine the incremental cost-effectiveness of PBI compared with whole-breast radiation therapy (WBRT) for estrogen receptor-positive postmenopausal women treated for early-stage breast cancer. METHODS AND MATERIALS We developed a Markov model to describe health states in the 15 years after radiotherapy for early-stage breast cancer. External beam (EB) and MammoSite (MS) PBI were considered and assumed to be equally effective, but carried different costs. Patients received tamoxifen, but not chemotherapy. Utilities, recurrence risks, and costs were adapted from the literature; the baseline utility for no disease after radiotherapy was set at 0.92. Probabilistic sensitivity analyses were performed to model uncertainty in the PBI hazard ratio, recurrence pattern, and patient utilities. Costs (in 2004 US dollars) and quality-adjusted life-years were discounted at 3%/y. RESULTS The incremental cost-effectiveness ratio for WBRT compared with EB-PBI was
Public Health Reports | 2006
Laura A. McCloskey; Erika Lichter; Corrine M. Williams; Megan R. Gerber; Eve Wittenberg; Michael L. Ganz
630,000/quality-adjusted life-year; WBRT strongly dominated MS-PBI. One-way sensitivity analysis found that results were sensitive to PBI hazard ratio, recurrence pattern, baseline recurrence risk, and no evidence of disease PBI utility values. Probabilistic sensitivity showed that EB-PBI was the most cost-effective technique over a wide range of assumptions and societal willingness-to-pay values. CONCLUSIONS EB-PBI was the most cost-effective strategy for postmenopausal women with early-stage breast cancer. Unless the quality of life after MS-PBI proves to be superior, it is unlikely to be cost-effective.
Journal of The American Academy of Dermatology | 2008
Matthew Delfino; Elizabeth W. Holt; Charles R. Taylor; Eve Wittenberg; Abrar A. Qureshi
Objective. This study investigated whether disclosure of violence to health care providers and the receipt of interventions relate to womens exit from an abusive relationship and to their improved health. Methods. A volunteer sample of 132 women outpatients who described intimate partner violence during the preceding year were recruited from multiple hospital departments and community agencies in suburban and urban metropolitan Boston. Through in-person interviews, women provided information on demographics, past year exposure to violence, past year receipt of interventions, and whether they disclosed partner violence to their health care provider. They also described their past month health status with the 12-Item Short-Form Health Survey and further questions. Results. Of the 132 women, 44% had exited the abusive relationship. Among those who were no longer with their partner, 55% received a domestic violence intervention (e.g. advocacy, shelter, restraining order), compared with 37% of those who remained with their partner. Talking to their health care provider about the abuse increased womens likelihood of using an intervention (odds ratio [OR]=3.9). Those who received interventions were more likely to subsequently exit (OR=2.6) and women no longer with the abuser reported better physical health based on SF-12 summary scores (p=0.05) than women who stayed. Conclusions. Health care providers may make positive contributions to womens access to intimate partner violence services. Intimate partner violence interventions relate to womens reduced exposure to violence and better health.
PharmacoEconomics | 2009
Davene R. Wright; Eve Wittenberg; J. Shannon Swan; Rebecca A. Miksad; Lisa A. Prosser
BACKGROUND Psoriasis is a chronic skin condition that has a major impact on health-related quality of life (QOL). We evaluated health-related QOL via willingness to pay and a ranking task for 8 domains of health relevant to psoriasis: intimacy, physical comfort, self-care, ability to work or volunteer, ability to concentrate, emotional health, social comfort, and ability to sleep. OBJECTIVE The goals of the study were to pilot test a new method to measure QOL impact in psoriasis and identify the areas of life most affected by psoriasis. METHODS Forty participants with a history of psoriasis were interviewed in a face-to-face format. First, participants were asked to rank the 8 domains of health we were investigating. Second, patients were asked how much money they would be willing to pay for a hypothetical cure for each domain of health. Responses in US dollars were interpreted as strength of preference rather than absolute monetary values. RESULTS About half of the patients in the sample (48%) were female, 60% had a college degree or further education, and 38% had an income level over
Violence Against Women | 2008
Kristie A. Thomas; Manisha Joshi; Eve Wittenberg; Laura A. McCloskey
45,000/y. Physical comfort, social comfort, and emotional health were highly ranked by more than 75% of respondents. Ability to concentrate was least likely to be affected by psoriasis with just a quarter (25.7%) of respondents ranking this domain as important. The median amount patients were willing to pay for a hypothetical cure of psoriasis specific to a particular domain was highest for physical comfort (
Medical Decision Making | 2013
Eve Wittenberg; Grant Ritter; Lisa A. Prosser
2000, 25th quartile =
Medical Decision Making | 2012
Eve Wittenberg; Grant Ritter; Lisa A. Prosser
500, 75th quartile =